Additionally, mice treated with M-gp100.2L and D-gp100.2L showed localised vitiligo at the site of vaccination, while mice vaccinated with gp100.2L without mannosylation did not demonstrate vitiligo (Figure S4). Here, PMEL is linked to vitiligo.